BCL2L11 and neoplasm: Giulia-Romano found that the increased expression of miR-494 lead to the Tumor necrosis factor Related Apoptosis-Inducing Ligand (TRAIL) resistance in NSCLC via down regulation of BCL2L11, which may inhibit the apoptosis and promote the tumorigenicity of tumor cells [28].